Ilenia Pantano

1.2k total citations
25 papers, 711 citations indexed

About

Ilenia Pantano is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Ilenia Pantano has authored 25 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 11 papers in Hematology and 11 papers in Immunology. Recurrent topics in Ilenia Pantano's work include Autoimmune and Inflammatory Disorders Research (11 papers), Spondyloarthritis Studies and Treatments (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Ilenia Pantano is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (11 papers), Spondyloarthritis Studies and Treatments (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Ilenia Pantano collaborates with scholars based in Italy, Belarus and France. Ilenia Pantano's co-authors include Roberto Giacomelli, Piero Ruscitti, Paola Cipriani, Vasiliki Liakouli, Francesco Carubbi, Onorina Berardicurti, Serena Fasano, Paola Di Benedetto, Gabriele Valentini and Michele Iudici and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Ilenia Pantano

25 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilenia Pantano Italy	14	256	249	213	178	150	25	711
I. Koetter Germany	16	283 1.1×	267 1.1×	149 0.7×	276 1.6×	210 1.4×	28	844
Aşkın Ateş Türkiye	17	136 0.5×	324 1.3×	114 0.5×	135 0.8×	101 0.7×	81	818
Daiki Nakagomi Japan	16	181 0.7×	470 1.9×	105 0.5×	107 0.6×	108 0.7×	61	906
Kimihiro Suzuki Japan	16	244 1.0×	291 1.2×	168 0.8×	103 0.6×	101 0.7×	59	869
Francisco Javier López‐Longo Spain	16	184 0.7×	563 2.3×	125 0.6×	73 0.4×	79 0.5×	52	797
Ja‐Young Jeon South Korea	16	474 1.9×	497 2.0×	129 0.6×	158 0.9×	112 0.7×	34	868
Radjiv Goulabchand France	13	160 0.6×	179 0.7×	51 0.2×	114 0.6×	227 1.5×	49	615
Eren Erken Türkiye	16	195 0.8×	221 0.9×	71 0.3×	259 1.5×	120 0.8×	60	706
Giovanni Ciancìo Italy	17	283 1.1×	499 2.0×	270 1.3×	122 0.7×	43 0.3×	45	891
Cleonice Bueno Brazil	15	229 0.9×	316 1.3×	67 0.3×	100 0.6×	94 0.6×	40	630

Countries citing papers authored by Ilenia Pantano

Since Specialization

Citations

This map shows the geographic impact of Ilenia Pantano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilenia Pantano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilenia Pantano more than expected).

Fields of papers citing papers by Ilenia Pantano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilenia Pantano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilenia Pantano. The network helps show where Ilenia Pantano may publish in the future.

Co-authorship network of co-authors of Ilenia Pantano

This figure shows the co-authorship network connecting the top 25 collaborators of Ilenia Pantano. A scholar is included among the top collaborators of Ilenia Pantano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilenia Pantano. Ilenia Pantano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruscitti, Piero, Ilenia Pantano, Francesco Arrigoni, et al.. (2024). Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort. Lara D. Veeken. 64(3). 1122–1130. 3 indexed citations

Carletto, Antonio, Alen Zabotti, Roberta Ramonda, et al.. (2023). Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study. Arthritis Research & Therapy. 25(1). 196–196. 1 indexed citations

Mauro, Daniele, Ilenia Pantano, Saverio Naty, et al.. (2023). Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study. Journal of Clinical Medicine. 12(9). 3248–3248. 1 indexed citations

Scriffignano, Silvia, Rik Lories, A. Nzeusseu Toukap, et al.. (2022). Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations. Clinical and Experimental Rheumatology. 41(9). 1815–1822. 5 indexed citations

Mauro, Daniele, Ilenia Pantano, Laura Bucci, et al.. (2022). Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort. Frontiers in Immunology. 13. 901055–901055. 11 indexed citations

Pantano, Ilenia, Daniele Mauro, Francesca Romano, et al.. (2021). Real-life efficacy of guselkumab in patients with early psoriatic arthritis. Lara D. Veeken. 61(3). 1217–1221. 19 indexed citations

Ruscitti, Piero, Onorina Berardicurti, Daniela Iacono, et al.. (2020). Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients. Arthritis Research & Therapy. 22(1). 151–151. 29 indexed citations

Berardicurti, Onorina, Alessandro Conforti, Daniela Iacono, et al.. (2020). Dissecting the clinical heterogeneity of adult-onset Still’s disease: results from a multi-dimensional characterization and stratification. Lara D. Veeken. 60(10). 4844–4849. 25 indexed citations

Benedetto, Paola Di, Paola Cipriani, Daniela Iacono, et al.. (2020). Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort. PLoS ONE. 15(7). e0235326–e0235326. 33 indexed citations

10.

Liakouli, Vasiliki, Paola Cipriani, Paola Di Benedetto, et al.. (2019). Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts. Scientific Reports. 9(1). 4589–4589. 13 indexed citations

11.

Ruscitti, Piero, Paola Cipriani, Vasiliki Liakouli, et al.. (2019). Prescribing motivations and patients’ characteristics related to the use of biologic drugs in adult-onset Still’s disease: analysis of a multicentre “real-life” cohort. Rheumatology International. 40(1). 107–113. 19 indexed citations

12.

Iudici, Michele, Ilenia Pantano, Serena Fasano, et al.. (2017). Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. Lupus. 27(2). 265–272. 26 indexed citations

13.

Fasano, Serena, et al.. (2017). Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. 44(7). 1032–1038. 82 indexed citations

14.

Cipriani, Paola, Paola Di Benedetto, Hermann Dietrich, et al.. (2016). Searching for a good model for systemic sclerosis: the molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis. Archives of Medical Science. 4(4). 828–843. 8 indexed citations

15.

Iudici, Michele, Serena Fasano, Ilenia Pantano, et al.. (2016). Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: a long-term retrospective cohort study. Lara D. Veeken. 55(9). 1623–1630. 29 indexed citations

16.

Cipriani, Paola, Paola Di Benedetto, Piero Ruscitti, et al.. (2015). The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. The Journal of Rheumatology. 42(10). 1808–1816. 88 indexed citations

17.

Cipriani, Paola, Paola Di Benedetto, Daria Capece, et al.. (2014). Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis. PubMed. 7(1). 13–13. 24 indexed citations

18.

Cipriani, Paola, Paola Di Benedetto, Piero Ruscitti, et al.. (2014). Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. Arthritis Research & Therapy. 16(5). 442–442. 44 indexed citations

19.

Cipriani, Paola, Piero Ruscitti, Francesco Carubbi, et al.. (2013). Tocilizumab for the treatment of adult-onset Still’s disease: results from a case series. Clinical Rheumatology. 33(1). 49–55. 74 indexed citations

20.

Carubbi, Francesco, Paola Cipriani, Alessandra Marrelli, et al.. (2013). Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. Arthritis Research & Therapy. 15(5). 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact